David A. Barbie is an Associate Professor of Medicine, Harvard Medical School and a Medical Oncologist at Medical Oncology, Dana-Farber Cancer Institute. His laboratory is interested in exploring the NF-kB pathway through genetic and small molecule approaches as a means of targeting KRAS-driven lung cancer. He has an h-Index of 46, and his papers have been cited more than 12,900 times (Scopus, 13 October 2023).